The global surgical sutures market is witnessing steady growth as healthcare systems worldwide experience a rising number of surgical procedures, increasing chronic disease prevalence, and a growing aging population requiring medical care. Advances in wound closure technologies, greater adoption of minimally invasive procedures, and the development of specialized products such as absorbable, antimicrobial, and barbed sutures are further supporting industry expansion. Growing healthcare infrastructure, improved access to surgical care, and increasing focus on patient safety and faster recovery are also encouraging the adoption of advanced surgical suture solutions across hospitals and surgical centers.

Key Market Figures

• Market size in 2025: USD 5.0 billion

• Estimated market size in 2026: USD 5.3 billion

• Projected market size by 2033: USD 7.4 billion

• CAGR, 2026–2033: 5.0%

• North America revenue share in 2025: 44.1%

The growing number of surgical procedures is one of the strongest factors supporting demand for surgical sutures. Grand View Research notes that approximately 313 million surgeries are performed annually worldwide, while an estimated 143 million additional procedures are needed each year to meet essential healthcare requirements, particularly in low-resource regions. Since most surgical and traumatic wounds require some form of closure, the increasing volume of procedures directly supports demand for dependable suturing products.

Download a free sample copy of the Surgical Sutures Market report to understand detailed coverage and inclusions in the final report

Technological Advancements Transforming Surgical Sutures

Product innovation is becoming an important factor in the development of modern surgical sutures. Manufacturers are increasingly focusing on absorbable, antimicrobial, barbed, and other specialized solutions designed to improve wound closure, support healing, and reduce complications.

Antimicrobial-coated sutures are gaining attention because they are designed to help reduce the risk of surgical-site infections. At the same time, barbed sutures can improve surgical efficiency by reducing or eliminating the requirement for conventional knot tying. Synthetic absorbable materials such as polyglycolic acid (PGA) and polydioxanone (PDO) also provide controlled degradation and tissue support during the healing process.

The development of these technologies reflects a broader shift toward sutures that offer improved biocompatibility, tensile strength, handling, and wound-healing performance. As minimally invasive and advanced surgical procedures become more common, manufacturers are also working to develop products compatible with increasingly precise surgical techniques.

Absorbable Sutures Maintain Strong Demand

By type, the absorbable segment held the largest market share in 2025 and is expected to record the fastest CAGR during the forecast period. Absorbable sutures provide temporary wound support and naturally degrade after serving their purpose, eliminating the need for a separate removal procedure in many applications.

These products may be manufactured from natural materials such as catgut or synthetic polymers including polyglycolic acid, polylactic acid, and polydioxanone. Synthetic absorbable sutures undergo hydrolytic degradation, providing a more predictable absorption profile. Their ability to provide tissue support during the critical healing period makes them particularly useful across numerous surgical applications.

Non-absorbable sutures also remain important because of their durability and ability to provide long-term structural support. They continue to be used in procedures where extended wound support is required.

Filament Innovation Creates New Opportunities

The filament structure represents another important area of competition. According to Grand View Research, the multifilament segment accounted for the largest market share in 2025, supported by characteristics such as flexibility, compliance, and high tensile strength. Meanwhile, the monofilament segment is projected to register the fastest CAGR over the forecast period.

Monofilament sutures feature a single-strand structure that can provide reduced tissue trauma and improved handling during surgical procedures. Their lower tendency to harbor microorganisms compared with some multifilament structures can also make them attractive for applications where infection control is an important consideration.

General Surgery Leads Applications

By application, general surgery held the largest share in 2025. Surgical sutures are extensively used in general procedures for wound closure and tissue approximation, creating consistent demand across hospitals and surgical centers.

The cardiovascular segment, meanwhile, is expected to experience the fastest growth during the forecast period. Rising cardiovascular disease prevalence, improving diagnostic capabilities, supportive reimbursement environments, and expanding access to specialized cardiac procedures are contributing to this growth.

North America Remains the Leading Region

North America dominated the global surgical sutures market in 2025, accounting for a 44.1% revenue share. The region benefits from sophisticated healthcare infrastructure, established surgical facilities, strong reimbursement systems, and the presence of major medical technology companies.

The U.S. represents the largest national market within North America. Its strong healthcare expenditure, extensive research and development activities, and emphasis on medical innovation support continued demand. The country's aging population also contributes to surgical requirements associated with cardiovascular, orthopedic, ophthalmic, and other age-related conditions.

Asia Pacific is another important growth region. Increasing surgical volumes, improving healthcare infrastructure, rising healthcare access, and the growing prevalence of chronic diseases in countries such as China, India, and Japan are creating new opportunities. The region is also witnessing greater adoption of advanced absorbable and antimicrobial sutures and increased local manufacturing.

Looking for more specific insights? Customize this report to suite your business needs

Competitive Landscape and Future Outlook

The competitive environment includes major companies such as:

Key Surgical Sutures Companies:

The following key companies have been profiled for this study on the surgical sutures market.

• Medtronic

• Stryker

• Smith+Nephew

• Ethicon (Johnson & Johnson)

• B. Braun SE

• Riverpoint Medical

• Dynarex Corporation

• Healthium Medtech Ltd

• Lotus Surgicals Pvt Ltd (TI Medical, a Murugappa Group company)

• DemeTECH Corporation

• Corza Medical

• Advanced Medical Solutions Group plc

• Meril

Overall, the surgical sutures industry is positioned for continued development as healthcare providers seek reliable wound closure technologies that can support efficient procedures and improved patient outcomes. Increasing surgical volumes, an aging population, chronic disease prevalence, technological innovation, and expanding healthcare infrastructure are expected to remain important growth factors. With the global market projected to increase from USD 5.3 billion in 2026 to USD 7.4 billion by 2033, surgical sutures are likely to remain an essential component of modern surgical care.

Related Reports: 

• Ophthalmic Handheld Surgical Instruments Market Size, Share & Trends Analysis Report By Product (Forceps, Scissor, Chopper, Ophthalmic Knives, Cannula), By End Use (Hospitals, Ophthalmic Clinics), By Region, And Segment Forecasts

• Disposable Surgical Devices Market Size, Share & Trends Analysis Report By Product (Surgical Sutures & Staplers, Electrosurgical Devices, Handheld surgical Devices), By Application (Neurosurgery, Cardiovascular, Orthopedic), By Region, And Segment Forecasts

• Cyanoacrylate Surgical Sealants And Adhesives Market Size, Share & Trends Analysis Report By Product (n-Butyl Cyanoacrylate-based Sealants, 2-Octyl Cyanoacrylate-based Sealants), By Application, By End-use, By Region, And Segment Forecasts